# BBWI - Bath & Body Works, Inc. (v2.0)

**Date:** 2026-02-03
**Status:** WATCHLIST
**Tier:** C (Turnaround/Speculative)
**Quality Score:** 3/10
**Decision:** WATCHLIST - Standing order at $18.50 is correct, wait for Q4 earnings visibility

---

## 1. Executive Summary

Bath & Body Works es un retailer especializado en fragancias corporales, body care, y home fragrances (velas 3-wick, Wallflowers). Cotiza a 7.1x P/E y ~14% FCF yield, muy por debajo de specialty retail peers (~19x). La baratura esta justificada por: (1) ingresos en declive -7% desde FY2022, (2) $5B de deuda con equity negativo (-$1.4B), (3) estrategia de crecimiento fallida que requiere turnaround, (4) litigio de fraude de valores activo. Sin embargo, genera ~$660M FCF/ano, cubre intereses 5.1x, y ha refinanciado deuda hasta 2029-2034.

**Por que esta barata:** Declive de revenue, leverage extremo, equity negativo, turnaround no probado
**Mi contra-tesis:** FCF sigue siendo robusto (~14% yield), deuda refinanciada con maturities extendidas, categoria de fragancias crece 5-6% anual, optionalidad de turnaround
**Catalizador principal:** Q4 earnings 19-Feb-2026 + FY2027 guidance - critico para visibilidad
**Fair value base:** $29 | Precio actual: $22.82 | MoS: 23% (INSUFICIENTE para Tier C que requiere 35%)

---

## 2. Business Understanding

### 2.1 Modelo de Negocio

| Aspecto | Descripcion |
|---------|-------------|
| Problema que resuelve | Experiencia sensorial/emocional (fragancias, self-care) a precio accesible - "affordable luxury" |
| Cliente target | Mujeres 18-54, preferencia por fragancia/body care, sensibles a precio pero buscan indulgencia |
| Como genera ingresos | Transaccional (retail) + consumibles (repeat purchase de refills) |
| % ingresos recurrentes | ~20-25% estimado (loyalty 80% de ventas pero no suscripcion) |

**Modelo:** Verticalmente integrado - diseno, marketing, y supply chain in-house. ~1,850 tiendas (mayoria mall-based). 39M loyalty members generan 80% de ventas US.

**Categorias:**
- Body care (lotions, shower gels)
- Body fragrance (mists, perfumes)
- Home fragrance (3-wick candles, Wallflowers, diffusers)
- Hand soaps

### 2.2 Unit Economics

| Metrica | Valor | Benchmark | Comentario |
|---------|-------|-----------|------------|
| AUR (Avg Unit Retail) | +LSD YoY | - | Mix shift to premium |
| Sales/sq ft | ~$900-1,000 | $400 avg retail | Strong productivity |
| Loyalty penetration | 80% | - | High but base shrinking |
| New customer acquisition | FAILING | - | Management admitted strategy failed |

### 2.3 Estructura de Margenes

| Margen | FY2022 | FY2025 | TTM | Tendencia | vs Peers |
|--------|--------|--------|-----|-----------|----------|
| Gross | 45.3% | 44.5% | 44.1% | Comprimiendo | En linea |
| Operating | 25.5% | 17.4% | 10.1% | **FUERTE COMPRESION** | Bajo |
| Net | 16.9% | 10.9% | ~7% | Bajando | Bajo |
| FCF/Revenue | 15.5% | 9.0% | ~9% | Estable post-compression | Decente |

**Analisis:** Compresion de 25% a 10% operating margin es critica. Causas: promociones elevadas, tariffs $85M, deleverage operativo. $250M cost savings puede estabilizar pero no restaurar a 25%.

### 2.4 Por Que Esta Barata

**Narrativa del mercado:**
1. Declive secular - candles/body care discretionary, malls muriendo
2. Disrupcion competitiva - Sephora/Ulta ganando, DTC brands, Amazon
3. Balance insostenible - $5B deuda con equity negativo
4. Turnaround incierto - CEO nuevo, 0 track record
5. Litigio - Securities fraud class action

**Mi contra-tesis:**

| Mercado cree | Yo creo | Evidencia | Prob. equivocado |
|--------------|---------|-----------|------------------|
| Declive secular | Categoria crece 5-6% | Home fragrance TAM $7.2B, CAGR 6.2% | 30% |
| Disrupcion competitiva | BBWI tiene dominance en categorias | Teens returning (top 10 first time in 6yr) | 35% |
| Balance insostenible | Deuda refinanciada, FCF cubre | Maturities 2029-2034, coverage 5.1x | 25% |
| Turnaround incierto | FCF provee colchon | $660M FCF, $250M cost savings | 40% |

### 2.5 Value Trap Checklist

| Factor | SI/NO | Comentario |
|--------|-------|------------|
| Industria en declive secular | NO | Home fragrance crece 6%+, body care 5%+ |
| Disrupcion tecnologica inminente | NO | Experiencia fisica/sensorial |
| Management destruyendo valor | PARCIAL | Failed strategy, pero buybacks ayudan |
| Balance deteriorandose | SI | Equity -$1.4B, deuda estable |
| Insider selling masivo | NO | No evidencia |
| Dividend cut reciente/probable | PARCIAL | Safe ahora, at risk si FCF < $500M |
| Perdida market share >2pp/3y | PARCIAL | Estable pero nuevos clientes no llegan |
| ROIC < WACC ultimos 3 anos | NO | ROIC ~30%+ vs WACC ~11% |
| FCF negativo >2 anos | NO | $660M positivo |
| Goodwill >50% equity | N/A | Equity negativo |

**Total SI/PARCIAL:** 5-6 factores = **ZONA ROJA** (requiere 35%+ MoS)

---

## 3. Key Metrics

| Metrica | Valor | Sector Avg | Comentario |
|---------|-------|-----------|-----------|
| Price | $22.82 | | -47% from 52w high |
| Market Cap | $4.7B | | |
| P/E | 7.1x | ~19x | Deep discount |
| P/E Forward | 8.7x | | Earnings decline implied |
| FCF Yield | ~14% | | Very high |
| EV/EBITDA | ~6.0x | | |
| Dividend Yield | 3.6% | | |
| Total Debt | $4.96B | | |
| Net Debt | $4.3B | | |
| Stockholders Equity | -$1.39B | | NEGATIVE |
| Gross Margin | 44.1% | | |
| Operating Margin | 10.1% | | Down from 25% |
| Interest Coverage | 5.1x | | Adequate |

---

## 4. Projections

### 4.1 Revenue Drivers

| Driver | Valor | Fuente |
|--------|-------|--------|
| TAM (Home + Body Care US) | ~$22B | Precedence/Mordor |
| TAM growth | 5.5% blended | GMI/Mordor |
| Market share actual | ~33% | Estimated |
| Market share trend | Losing slightly | |
| Pricing power | MODERATE | AUR +LSD |

**Revenue growth derivado:** TAM +5.5% - share loss 1.5% + pricing +1% = +5% theoretical
**REALIDAD:** Company guiding NEGATIVE. BBWI is significantly underperforming TAM.

### 4.2 Projection Table

| Ano | Revenue | Op. Margin | FCF |
|-----|---------|------------|-----|
| FY2025 (actual) | $7.31B | 17.4% | $660M |
| FY2026 | $7.1B | 14% | $500-550M |
| FY2027 | $7.1-7.2B | 15% | $550-600M |
| FY2028+ | $7.3-7.5B | 15-16% | $600-650M |

### 4.3 WACC Derivado

```
Risk-free: 4.2% | Beta: 1.6 | ERP: 5.5%
Ke = 4.2% + (1.6 x 5.5%) = 13.0%
Kd after-tax = 7.5% x (1-0.25) = 5.6%
E/V = 49% | D/V = 51%
WACC = 9.3% + 1.5% turnaround risk = 10.8% (rounded to 11%)
```

---

## 5. Valuation (Multi-Method)

### 5.1 Method 1: DCF (via dcf_calculator.py --scenarios)

| Scenario | Assumptions | Fair Value |
|----------|-------------|------------|
| Bear | Growth -2%, WACC 12%, Terminal 1.5% | $21.83 |
| Base | Growth 3%, WACC 11%, Terminal 2% | $33.43 |
| Bull | Growth 5%, WACC 10%, Terminal 2.5% | $49.86 |

### 5.2 Method 2: EV/EBIT Normalized

```
EBIT normalized (5y avg): ~$1.3B
Retail distressed multiple: 6-8x (using 7x conservative)
EV = $9.1B
Net Debt = $4.3B
Equity Value = $4.8B
Fair Value = $23.40/share
```

### 5.3 Method 3: P/E Forward

```
FY2027 EPS: ~$2.80
Distressed retail P/E: 8-10x
At 8x: $22.40
At 10x: $28.00
```

### 5.4 Reconciliation

| Method | Bear | Base | Bull | Weight |
|--------|------|------|------|--------|
| DCF | $21.83 | $33.43 | $49.86 | 40% |
| EV/EBIT | $23.40 | $26.70 | $30.00 | 35% |
| P/E Forward | $22.40 | $28.00 | $33.60 | 25% |
| **Weighted Avg** | **$22.50** | **$29.00** | **$38.00** | |

### 5.5 Expected Value

```
Expected Value = ($22.50 x 25%) + ($29.00 x 50%) + ($38.00 x 25%)
Expected Value = $29.63

Current Price: $22.82
MoS vs Expected Value: 23%
MoS vs Bear Case: -1.4% (NEGATIVE - no margin on bear)
```

---

## 6. Moat Assessment

| Fuente | Presente? | Fortaleza | Evidencia | Durabilidad |
|--------|-----------|-----------|-----------|-------------|
| Cost Advantage | NO | 1/5 | Margenes en linea | N/A |
| Network Effects | NO | 1/5 | No aplica | N/A |
| Intangibles (Brand) | SI | 3/5 | Premium pero erosionando | 5-10y |
| Switching Costs | PARCIAL | 2/5 | Loyalty 80% sin lock-in | 3-5y |
| Efficient Scale | SI | 3/5 | 3-wick candles dominance | 5-10y |

**Moat Type: NARROW (deteriorating toward NONE)**

**Durabilidad estimada:** 5-10 anos

**Amenazas principales:**
1. Cambio preferencias consumidor (ALTA prob)
2. Competencia digital-first (MEDIA prob)
3. Mall decline (MEDIA prob)

---

## 7. Risks

| Riesgo | Prob | Impacto | Mitigante |
|--------|------|---------|-----------|
| Revenue no estabiliza | ALTA | ALTO | $250M cost savings |
| Leverage crisis | BAJA | MUY ALTO | Refinanciado 2029-2034 |
| Turnaround execution fail | ALTA | ALTO | FCF provee tiempo |
| Securities litigation | MEDIA | MEDIO | Manageable settlement |
| Dividend cut | MEDIA | MEDIO | At risk si FCF < $500M |
| Tariffs escalation | MEDIA | MEDIO | Supply chain mitigation |
| Consumer recession | MEDIA | ALTO | Discretionary vulnerable |

**Kill Conditions (sell immediately if):**
1. Interest coverage < 3x
2. Dividend cut
3. FY2027 guidance shows continued revenue decline
4. FCF falls below $400M annual

---

## 8. Catalysts

| Catalizador | Timeframe | Prob | Impacto |
|-------------|-----------|------|---------|
| Q4 FY2026 earnings | 19-Feb-2026 | - | CRITICAL for FY2027 visibility |
| Revenue stabilization | 6-12m | MEDIA | +30-50% |
| Amazon partnership launch | 2026 | MEDIA | +10-20% |
| Cost savings realization | 6-12m | ALTA | Margin support |

---

## 9. Macro Connection

| Factor | Sensibilidad | Status | Impacto |
|--------|--------------|--------|---------|
| Tasas de interes | ALTA | Estable | Neutro - deuda refinanciada |
| Recesion US | ALTA | 25% prob | NEGATIVO - discretionary |
| Inflacion | MEDIA | 3% PCE | NEGATIVO - consumer squeeze |
| Consumer confidence | ALTA | Debil | NEGATIVO |
| Tariffs | MEDIA | Escalando | NEGATIVO - $85M |

**Fit con World View:** CAUTELA - Late-cycle, tariffs escalando, discretionary retail no es ideal.

---

## 10. Decision (7 Gates)

| Gate | Status |
|------|--------|
| 1. Business understanding | PASS |
| 2. Proyeccion fundamentada | PASS |
| 3. Valoracion multi-metodo | PASS |
| 4. Margen de seguridad (35% req) | **FAIL** (23% actual) |
| 5. Contexto macro | **FAIL** (late-cycle, discretionary) |
| 6. Portfolio fit | PASS |
| 7. Autocritica explicita | PASS |

**VERDICT: 5/7 Gates = DO NOT BUY at current price**

| Campo | Valor |
|-------|-------|
| Recomendacion | WATCHLIST |
| Tier | C (Turnaround) |
| MoS requerido | 35% |
| MoS actual | 23% |
| Fair Value Base | $29.00 |
| **Correct trigger price** | **$18.85** (35% MoS) |
| Standing order | $18.50 (CORRECT) |
| Next catalyst | Q4 earnings 19-Feb-2026 |

---

## 11. Value Trap vs Genuine Opportunity Assessment

**VERDICT: HIGH-RISK TURNAROUND, NOT A CLASSIC VALUE TRAP**

Differences vs HPQ (classic value trap):
- HPQ had irreversible secular decline (printing). BBWI is in a category GROWING 5-6%.
- HPQ had complete commoditization. BBWI has brand loyalty (80% sales from members).
- HPQ couldn't generate sustainable FCF. BBWI generates $660M FCF.

But BBWI has:
- NEGATIVE equity (worse than HPQ)
- Unproven turnaround (new CEO, new strategy)
- 5-6 red flags on value trap checklist

**Conclusion:** It's a **legitimate turnaround opportunity** but current price does NOT offer sufficient MoS for the risk. At $18.50 (35% MoS), risk/reward is attractive. At $22.82, bear case downside is -1% and base case upside is +27% - not enough asymmetry.

---

## 12. Autocritica

| Aspecto | Respuesta |
|---------|-----------|
| Asunciones no validadas | 1. $250M cost savings materialize 2. Amazon partnership impact |
| Sesgos posibles | 1. Attracted by low P/E 2. High FCF yield may be temporary |
| Que me haria cambiar | 1. 2+ quarters revenue growth 2. Margin improvement not just cost cutting |
| Mi ventaja informacional | NONE - market probably right to be skeptical |
| Que podria estar mal | Turnaround could take 5+ years, consuming FCF |

---

## Metadata

```yaml
ticker: BBWI
fecha_creacion: 2026-02-02
ultima_revision: 2026-02-03
autor: fundamental-analyst (orchestrator v2.0)
status: watchlist
next_review: 2026-02-19 (post Q4 earnings)
standing_order: $18.50
earnings_date: 2026-02-19
framework_version: v2.0
```

---

## Sources

- [Bath & Body Works IR - Q3 2025 Results](https://investors.bbwinc.com/news-releases/news-release-details/bath-body-works-outlines-strategic-transformation-sustainable)
- [TipRanks - BBWI Earnings](https://www.tipranks.com/stocks/bbwi/earnings)
- [Precedence Research - Home Fragrance Market](https://www.precedenceresearch.com/home-fragrance-market)
- [Mordor Intelligence - Home Fragrances Market](https://www.mordorintelligence.com/industry-reports/home-fragrances-market)
- [GMI - Fragrance Product Market](https://www.gminsights.com/industry-analysis/fragrance-product-market)
- [Simply Wall St - BBWI Financial Health](https://simplywall.st/stocks/us/retail/nyse-bbwi/bath-body-works/health)
- [Retail Brew - Teen Market Share](https://www.retailbrew.com/stories/2025/04/22/ulta-target-lose-beauty-share-with-teens-while-bath-and-body-works-mounts-a-comeback)
- [Valens Research - BBWI Credit Analysis](https://www.valens-research.com/investor-essentials-daily/bbwi-bath-body-works-specialty-retailer-much-safer-rating-agencies-think/)
- yfinance (price data)
